Stephen J. Aselage is a businessperson who has been at the head of 6 different companies. Currently, Mr. Aselage is Chairman at Acer Therapeutics, Inc. and Chief Executive Officer for Kyalin Biosciences, Inc.

He is also on the board of BioCryst Pharmaceuticals, Inc. and Patara Pharma LLC.

In the past he occupied the position of Director at Travere Therapeutics, Inc. Chairman of Desert Gateway, Inc. and Chief Executive Officer & Director at Retrophin LLC (both are subsidiaries of Travere Therapeutics, Inc.), Executive VP-Global Commercial Operations at CTI BioPharma Corp., Chief Business Officer & Executive Vice President at BioMarin Pharmaceutical, Inc., Director-Sales & Marketing at Advanced Tissue Sciences, Inc., Chairman at Acer Therapeutics, Inc., Sales Manager at Genentech, Inc., Senior VP-North American Sales & Marketing at SangStat Medical Corp., Senior VP-North American Sales & Marketing at Genzyme Corp. and Sales Manager at Rorer Pharmaceuticals, Inc.

He received an undergraduate degree from the University of Notre Dame.